Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
October 14, 2026
Key driver of aggressive prostate cancer identified, suggesting new way to reverse drug resistance
A Nature study reveals that a single transfer RNA (tRNA) helps determine whether prostate cancer remains treatment-sensitive or becomes resistant, opening new avenues in precision oncology
Fred Hutch and UW MD/PhD candidate wins ARCS leadership award
Alex Doan honored for pioneering glycobiology research and community leadership
Study uncovers genomic architecture and natural history of metastatic bladder cancer
Published in Nature, a new study using a first-in-kind rapid autopsy program shows details of metastatic bladder cancer subtypes; could improve diagnosis and future treatment
Matching tumors to treatments: An updated roadmap for head and neck squamous cell carcinoma
From the Gujral Lab, Human Biology Division
A tale of resistance: Losing USP22 lets small cell lung cancer rewrite its own SAGA
From the MacPherson Lab, Human Biology Division
Fred Hutch researchers discover molecular switch that helps prostate cancer quickly change its biology to evade therapy
Drs. Andrew Hsieh and Rashmi Mishra identify a key step in the protein-making process that turns a treatable form of prostate cancer into a more lethal, drug-resistant subtype — and a way to switch it back
Dr. Andrew Hsieh named Larry and Virginia Gordon Endowed Chair in Prostate and Bladder Cancer Research
A new endowed chair created by Larry and Virginia Gordon helps accelerate discoveries for bladder and prostate cancer
Small cell lung cancer research gets a boost
Drs. David MacPherson and Gavin Ha receive $1.5M from Andy Hill CARE Fund to create much-needed liquid biopsy for SCLC
Let cancer eat cake
Fred Hutch study finds that feeding NRF2-mutated tumors too much of a nutrient they crave makes them vulnerable to slower growth and cell death
Reprogramming pancreatic cancer to become more treatment responsive
From the Kugel Lab, Human Biology Division
Targeting oncogenic TRK fusion proteins for disposal
From the Nabet Lab and Holland Lab, Human Biology Division
Fred Hutch Cancer Center announces 2026 Evergreen Fund awardees
Eight Fred Hutch researchers receive nearly $1 million to advance projects with industry partnership potential
Two Fred Hutch postdocs receive prestigious Damon Runyon awards
The early-career scientists will study the biology of acute myeloid leukemia and how certain treatments can make immunocompromised cancer patients more vulnerable to lung infections
Mapping how translational machinery shapes lineage determination in prostate cancer
From the Hsieh Lab, Human Biology Division
Beyond neutralization: the secret life of ADCC antibodies
From the Overbaugh Lab, Human Biology Division
Fred Hutch names 8 recipients of the Dr. Eddie Méndez Award
Annual award celebrates early-career scientists’ research in cancer, infectious disease and basic sciences
Fred Hutch researchers receive Prostate Cancer Foundation Young Investigator Awards
Three-year projects explore epigenetics to make new therapies or make existing therapies work better